Macquarie Group Ltd. raised its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 19.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,077,278 shares of the medical instruments supplier’s stock after purchasing an additional 342,160 shares during the quarter. Macquarie Group Ltd. owned approximately 0.91% of DENTSPLY SIRONA worth $124,248,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Veritas Asset Management LLP lifted its holdings in DENTSPLY SIRONA by 2.6% during the 2nd quarter. Veritas Asset Management LLP now owns 6,201,155 shares of the medical instruments supplier’s stock valued at $402,083,000 after purchasing an additional 157,616 shares during the last quarter. Royce & Associates LP lifted its holdings in DENTSPLY SIRONA by 23.4% during the 2nd quarter. Royce & Associates LP now owns 126,650 shares of the medical instruments supplier’s stock valued at $8,212,000 after purchasing an additional 24,000 shares during the last quarter. Bronfman E.L. Rothschild L.P. lifted its holdings in DENTSPLY SIRONA by 78.7% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 11,886 shares of the medical instruments supplier’s stock valued at $771,000 after purchasing an additional 5,236 shares during the last quarter. Gateway Investment Advisers LLC lifted its holdings in DENTSPLY SIRONA by 8.4% during the 2nd quarter. Gateway Investment Advisers LLC now owns 19,408 shares of the medical instruments supplier’s stock valued at $1,258,000 after purchasing an additional 1,499 shares during the last quarter. Finally, Delta Lloyd Asset Management N.V. acquired a new stake in DENTSPLY SIRONA during the 2nd quarter valued at $15,624,000. 94.65% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “Macquarie Group Ltd. Increases Holdings in DENTSPLY SIRONA Inc. (XRAY)” was first published by Daily Political and is owned by of Daily Political. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/11/18/macquarie-group-ltd-increases-holdings-in-dentsply-sirona-inc-xray.html.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) traded up $0.37 during mid-day trading on Friday, reaching $67.55. The company had a trading volume of 1,390,000 shares, compared to its average volume of 2,070,000. The firm has a market capitalization of $15,600.00, a P/E ratio of 26.05, a PEG ratio of 2.59 and a beta of 1.27. DENTSPLY SIRONA Inc. has a fifty-two week low of $52.53 and a fifty-two week high of $67.95. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.59 and a current ratio of 2.32.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 EPS for the quarter, beating the Zacks’ consensus estimate of $0.66 by $0.04. The business had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $978.99 million. DENTSPLY SIRONA had a positive return on equity of 7.56% and a negative net margin of 20.33%. DENTSPLY SIRONA’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.66 earnings per share. analysts anticipate that DENTSPLY SIRONA Inc. will post 2.66 EPS for the current fiscal year.

Several equities research analysts have issued reports on the company. Barrington Research raised DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 price target for the company in a report on Monday, November 6th. TheStreet raised DENTSPLY SIRONA from a “c” rating to a “b-” rating in a report on Friday, November 3rd. Stifel Nicolaus lifted their target price on DENTSPLY SIRONA from $66.00 to $70.00 and gave the stock a “buy” rating in a report on Monday, November 6th. HC Wainwright reissued a “buy” rating and set a $68.00 target price on shares of DENTSPLY SIRONA in a report on Monday, November 6th. Finally, BidaskClub downgraded DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Friday, July 28th. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $67.00.

In related news, CFO Nicholas W. Alexos purchased 50,000 shares of the company’s stock in a transaction that occurred on Monday, November 13th. The stock was acquired at an average price of $65.85 per share, with a total value of $3,292,500.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Mark Thierer purchased 77,000 shares of the company’s stock in a transaction that occurred on Monday, November 13th. The stock was bought at an average cost of $66.04 per share, with a total value of $5,085,080.00. The disclosure for this purchase can be found here. 1.99% of the stock is owned by insiders.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.